Onward Medical BV

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

N5381R111

SEDOL

N/A

CIK

N/A

www.onwd.com

LEI:

FIGI: BBG012XY9655

ONWD

Onward Medical BV

GICS: - · Sector: - · Sub-Sector: -

PROFILER

NAME

Onward Medical BV

ISIN

NL0015000HT4

TICKER

ONWD

MIC

XAMS

REUTERS

ONWD.AS

BLOOMBERG

ONWD NA

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Thu, 09.01.2025

ONWARD Medical Announces First Commercial Sales of ARC-EX System

Research & Analysis

Thu, 19.12.2024

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System

Research & Analysis

Tue, 26.11.2024

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights

Research & Analysis

Tue, 12.11.2024

ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights

Research & Analysis

Mon, 28.10.2024

ONWARD® Medical Publishes Closing of Bookbuild Offering

Research & Analysis

Tue, 22.10.2024

ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40M including EUR 22.5M Cornerstone Investment from Ottobock SE & Co. KGaA

Research & Analysis

Thu, 19.09.2024

ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury

Research & Analysis

Tue, 10.09.2024

ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update

Research & Analysis

Tue, 03.09.2024

ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System

Research & Analysis

Tue, 27.08.2024

ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

SMART * AD

P R O D U C T S U G G E S T I O N S

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Onward Medical BV

ONWARD Medical Announces First Commercial Sales of ARC-EX System

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights

ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights

ONWARD® Medical Publishes Closing of Bookbuild Offering

ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA

ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury

ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update

ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System

ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update

Newsletter